Over the past two decades, it has consistently demonstrated multimodal geroprotective effects across cellular, animal, and early human studies
Its time to take the first step to a healthier version of you
BPC-157 has been researched to: Improve healing of many types of wounds Protect intestinal organs and prevents stomach ulcers Combats leaky gut, IBS, gastrointestinal cramps and Crohns disease Accelerate healing of skin burns Work as an anti-inflammatory Maintains integrity of mucosal lining GI tract Repair tissues of GIT, tendons, ligaments, brain, bone, etc
BPC 157 and Standard Angiogenic Growth Factors Key Findings: BPC-157, when compared to standard peptidergic angiogenic growth factors (EGF, FGF, VEGF), has been effective in all models of acute/chronic injury of the gastrointestinal tract, whether administered intraperitoneally, per-orally, or locally
Obstetrics and Gynecology Clinics, 48(1), 131-144
This conservative approach means patients often spend weeks simply waiting for natural healing to occur